To determine the amounts of circulating Ig in patients with stroke, we analyzed their plasma samples by immunoassay and revealed a substantial reduction in the circulating amounts of IgA but not IgG within 72 h of hospital admission compared to healthy controls (Fig. 1a and Extended Data Fig. 1a). This evidence concerns the gene CD79A and Stroke.